logo
logo

Kayo Thera, Inc. announced it raised $4 Million in an initial filing from an offering of $8 Million

Mar 24, 2022over 3 years ago

Amount Raised

$4 Million

Round Type

seed

PrincetonTherapeuticsBiotechnologyHealth Care

Company Information

Company

KayoThera, Inc.

Location

155 VILLAGE BLVD., SUITE 130

Princeton, West Virginia, United States

About

KayoThera, Inc. is an early-stage therapeutics company focused on the development of first-in-class, oral, small molecule inhibitors of the retinoid pathway. This pathway plays a critical role in a variety of serious diseases, including cardiometabolic diseases and cancer. KayoThera is developing therapies to treat diabetes and late-stage and metastatic cancers including breast, lung, pancreatic, colorectal, brain, and kidney cancers. The company was founded based on discoveries from Dr. Mark Esposito’s post-doctoral research at Princeton University and professor Yibin Kang, Ph.D. For more information, visit www.kayothera.com.

FundzWatch™ Score

88
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People